Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr;110(4):544-554.
doi: 10.1007/s00392-020-01730-w. Epub 2020 Sep 3.

Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review

Patricia Alphonse  1 , Sohaib Virk  1 , Jhonna Collins  2 , Timothy Campbell  1   3 , Stuart P Thomas  1   3 , Christopher Semsarian  4 , Saurabh Kumar  5   6
Affiliations

Prognostic impact of atrial fibrillation in hypertrophic cardiomyopathy: a systematic review

Patricia Alphonse et al. Clin Res Cardiol. 2021 Apr.

Abstract

Background: Atrial fibrillation (AF) is an important arrhythmia in hypertrophic cardiomyopathy (HCM).

Objectives: To conduct a systematic review of published literature to: (a) assess the incidence of AF in HCM and (b) examine the impact of AF on risk of thromboembolism, heart failure, sudden death and mortality in HCM.

Methods: Search of all major databases (Pubmed, MEDLINE, Embase, Cochrane, Scopus, Web of Science) was performed to April 2020 using the search terms "atrial fibrillation" AND/OR "hypertrophic cardiomyopathy" in the title or abstract. 51 of the 1,565 citations met the inclusion criteria.

Results: Using random-effects modelling, the estimated pooled prevalence of AF amongst 21,887 HCM patients (36 studies) was 22.3% (95%, 19.9-24.8) and the pooled incidence of AF was 2.5 cases per person-years (95% CI 1.9-3.0). 15,444 patients from 28 studies were included in analysis of outcome data (mean age was 49.9 years; 32.7% female; mean LVEF 69%). Over a median follow up duration of 6.9 years (range 2.8-11.7 years), AF, compared to sinus rhythm (SR), was associated with significantly increased risk of thromboembolism [relative risk (RR) 7.0; 95% CI 4.6-10.7; I2 = 57%], heart failure (RR 2.8; 95% CI 1.6-4.6; I2 = 82%), sudden death (RR 1.7; 95% CI 1.3-2.3; I2 = 0%), and all-cause mortality (RR 2.5; 95% CI 1.8-3.4; I2 = 69%).

Conclusions: AF is highly prevalent in patients with HCM. The presence of AF is associated with major adverse clinical outcomes. These findings suggest that both, aggressive screening and treatment of AF, are likely to have major prognostic impact on outcomes in HCM. Incidence, prevalence and prognostic impact of AF in HCM. In this systematic review, AF incidence was 2.5 cases per-person years, prevalence was 22.3%. AF in HCM was associated with a seven-fold increased risk of thromboembolism, 2.8-fold increased risk of heart failure, 1.7-fold increased risk of sudden death and 2.5-fold increased risk of all-cause mortality.

Keywords: Atrial fibrillation; Heart failure; Hypertrophic cardiomyopathy; Morbidity; Mortality; Sudden death; Thromboembolism.

PubMed Disclaimer

References

    1. Guttmann OP, Rahman MS, O'Mahony C, Anastasakis A, Elliott PM (2014) Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart (Br Card Soc) 100:465–472. https://doi.org/10.1136/heartjnl-2013-304276 - DOI
    1. Masri A, Kanj M, Thamilarasan M et al (2017) Outcomes in hypertrophic cardiomyopathy patients with and without atrial fibrillation: a survival meta-analysis. Cardiovasc Diagn Ther 7:36–44. https://doi.org/10.21037/cdt.2016.11.23 - DOI - PubMed - PMC
    1. Greenspan AM (1990) Hypertrophic cardiomyopathy and atrial fibrillation: a change of perspective. J Am Coll Cardiol 15:1286–1287 - DOI
    1. Tian T, Wang Y, Sun K et al (2013) Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy. Cardiology 126:258–264. https://doi.org/10.1159/000354953 - DOI - PubMed
    1. Cecchi F, Olivotto I, Montereggi A, Santoro G, Dolara A, Maron BJ (1995) Hypertrophic cardiomyopathy in Tuscany: clinical course and outcome in an unselected regional population. J Am Coll Cardiol 26:1529–1536. https://doi.org/10.1016/0735-1097(95)00353-3 - DOI - PubMed

Publication types

LinkOut - more resources